Gammaplan treatment planning system

Manufactured by Elekta

Sourced in Sweden

GammaPlan is a treatment planning system developed by Elekta. It is designed to facilitate the planning and delivery of radiation therapy using Elekta's Gamma Knife technology. The system provides tools for image acquisition, target localization, dose calculation, and plan optimization.

Automatically generated - may contain errors

Lab products found in correlation

Close spelling variants of this product

Leksell GammaPlan Treatment Planning System GammaPlan® system GammaPlan

2 protocols using gammaplan treatment planning system

Stereotactic Radiosurgery for Brain Metastases

Check if the same lab product or an alternative is used in the 5 most similar protocols

Patients were treated on the Gamma Knife U (1999-04), C (2005-08) or Perfexion (2009-20) units (Elekta AB, Stockholm). Patients underwent rigid frame xation placed by a neurosurgeon on the day of treatment. A high resolution stereotactic MRI was performed on a 3 Tesla MRI unit (GE Healthcare, Chicago, IL). Treatment planning was performed on the GammaPlan Treatment Planning System (Elekta AB, Stockholm). Dosing for brain metastases was based on the RTOG 90 - 05 guidelines (20) .

Lanier C.M., Pearce J., Isom S., Xing F., Lo H.W., Whitlow C.T., Ruiz J., White J.J., Laxton A.W., Tatter S.B., Cramer C.K, & Chan M.D. (2022). Long term survivors of stereotactic radiosurgery for brain metastases: do distant brain failures reach a plateau and what factors are associated with a brain metastasis velocity of zero?. Journal of neuro-oncology, 160(3).

+ Open protocol

+ Expand

Gamma Knife for Brainstem Metastases

Check if the same lab product or an alternative is used in the 5 most similar protocols

This study was approved by the Wake Forest University Institutional Review Board. The Wake Forest University Medical Center Gamma Knife Program Tumor Registry was searched for all patients receiving GKRS and having a brainstem metastasis. Patients were allowed to have had previous whole brain irradiation. Between February 2000 and December 2010 a total of 52 brainstem metastases were treated with GKRS in 44 individual patients. Clinical outcome measures were determined using the patents’ electronic medical records. Dosimetric data were obtained using patients’ archived plans using the GammaPlan^™ treatment planning system (Elekta AB, Stockholm, Sweden) and consisted of tumor size, prescribed dose and isodose level, number of lesions, and tumor location.

Kilburn J.M., Ellis T.L., Lovato J.F., Urbanic J.J., Bourland J.D., Munley M.T., deGuzman A.F., McMullen K.P., Shaw E.G., Tatter S.B, & Chan M.D. (2014). Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. Journal of neuro-oncology, 117(1), 167-174.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!